Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

April 30, 2009

Conditions
Incontinence
Interventions
DRUG

NRL001

Four single doses of NRL001 or placebo. NRL001 is administered at lower (5, 7.5 and 10 mg) or higher (10, 12.5 and 15 mg) doses in a slow release rectal suppository weighing either 1 g or 2 g.

Trial Locations (1)

BT2 7BA

Bio-Kinetic Europe Limited, Belfast

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Norgine

INDUSTRY